Document is current
Any future updates will be listed below
-
Authors
Chan, Yvonne http://orcid.org/0000-0002-8502-3214
Thamboo, Andrew V.
Han, Joseph K.
Desrosiers, Martin
- License Information
-
More Information
Article History
Received: 17 May 2023
Accepted: 24 July 2023
First Online: 28 July 2023
Declarations
:
: Not applicable.
: Not applicable.
: YC: Speaker fees: Sanofi, Glaxo Smith Kline (GSK). MD: Research Funding: Pfizer. Clinical trial funding AstraZeneca, GSK, and Sanofi. Equity holder: Probionase Therapies. JKH: Research consultant: Sanofi Regeneron, GSK, AstraZeneca. AVT: Speaker fees: Sanofi, GSK, AstraZeneca, Research funds: GSK.
